October 08, 2024
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On Sept. 17, 2024, Bionpharma Inc. recalled one lot of Atovaquone Oral Suspension because it was found to be contaminated with the bacteria Cohnella. In immunocompromised individuals, this could pose a risk for serious or deadly infections in areas of the heart or soft tissue. Atovaquone is an antimicrobial drug used for the prevention or treatment of infections, including lung infections caused by pneumocystis jirovecii pneumonia in adults and adolescents aged 13 years and older. For more information, see here.
Last updated: October 08, 2024